Find Academic Supervisors

Shetuan ZhangView profile

Professor

• Ion Channel Function
• Cardiac Arrhythmias
• Heart Disease
• +4 more

Shetuan Zhang is a Professor in the Department of Biomedical and Molecular Sciences at Queen's University, affiliated with the School of Medicine and Faculty of Health Sciences. His research focuses on ion channel function, particularly the HERG potassium channel's role in cardiac arrhythmias and sudden cardiac death. He holds cross appointments in the Translational Institute of Medicine (TIME) and collaborates widely on drug safety and channelopathies. Research interests include structural basis of ion channels, drug-channel interactions, and potassium channel physiology. Projects investigate mechanisms of drug-induced HERG block, hypokalemia effects, and autoimmune impacts on ion channels. His lab employs electrophysiology, molecular biology, and animal models to study channelopathies and arrhythmia prevention. Recent work highlights opioid and amiodarone effects on HERG channels, emphasizing translational implications for cardiac safety. Zhang's publications span 1995 to 2024, with notable contributions on channel regulation, drug interactions, and protease-mediated damage. His team explores therapies targeting channel stability to treat Long QT Syndrome and arrhythmias.

ERSEN ERASLANView profile

Associate Professor

• Physiology
• Renal Pathology
• Oxidative Stress
• +3 more

Erşen Eraslan is an Associate Professor and former Head of the Department of Physiology at Bandırma Onyedi Eylül University's Faculty of Medicine. Previously, he held academic roles at Yozgat Bozok University and Atatürk University. His research focuses on renal and organ ischemia-reperfusion injuries, oxidative stress mechanisms, and the therapeutic potential of natural compounds in pathological conditions. Research interests include the effects of phytochemicals on gastric ulcers, sepsis-induced organ damage, and reproductive organ injuries. He has conducted over 69 peer-reviewed articles, contributing to fields like nephrology, gastroenterology, and pharmacology. His work also explores drug development for conditions such as renal failure and inflammatory diseases. Erşen has received the Young Researcher Scientific Publication Award and led several national research projects funded by TÜBİTAK and universities. He has authored book chapters on experimental animal models in clinical sciences and serves as a referee for SCI-indexed journals like Food Function and Renal Failure. His teaching spans physiology courses in medicine and health sciences, emphasizing practical training in cellular and tissue systems. Administrative roles include departmental leadership and curriculum development.

• Pharmacology
• Clinical Pharmacy
• Cardiovascular Physiology
• +3 more

Katarina Mihajlović is an Assistant Professor in Clinical Pharmacy at the Faculty of Medical Sciences, University of Kragujevac. She holds a PhD in Clinical and Experimental Pharmacology (2022), a Master of Nutrition and Supplementation (2023), and a Bachelor’s degree in Pharmacy (2011), all from the University of Kragujevac. Her research focuses on cardiovascular pharmacology, oxidative stress mechanisms, and drug effects on cardiac function. She has authored 27 peer-reviewed articles, including 19 in SCI-ranked journals, and received the 2019 Canadian Journal of Physiology and Pharmacology Young Investigator Award. Since 2023, she also teaches Clinical Pharmacy at Singidunum University. Research highlights include studies on cisplatin analogues’ effects on isolated hearts, cardio-protective roles of botanical extracts, and SARS-CoV-2’s impact on maternal-fetal redox balance. She actively participates in international projects like BIOSINT and leads research at the Center for Preclinical and Functional Research. Her work bridges pharmacology, nutrition, and cardiovascular health, emphasizing translational applications. Education: BSc Pharmacy (2011), PhD Clinical Pharmacology (2022), MSc Nutrition (2023) Affiliations: University of Kragujevac (Assistant Professor), Singidunum University (2024/2025) Awards: Charter of Saint Sava (2023), Young Investigator Award (2019) Grants: 2 junior research projects at Faculty of Medical Sciences, Erasmus BIOSINT project Her lab investigations span drug cardiotoxicity modulation, oxidative stress biomarkers, and nutrition-based interventions for mental health. Recent articles emphasize diuretic effects in hypertension, phytochemical cardio-protection, and SARS-CoV-2 maternal-fetal interactions.

Serge AfeliView profile

Associate Professor

• Healthcare Innovation
• Entrepreneurship
• Health Equity
• +3 more

Serge Afeli is Associate Professor and Interim Associate Dean for Academic Affairs at Presbyterian College School of Pharmacy. His work bridges pharmacology, healthcare innovation, and global health equity. Research Focus: Specializations include: Pharmacology of urinary bladder smooth muscle Entrepreneurship education in healthcare Inclusive curriculum design Global health disparities Awards & Honors: MIT Grand Hack Medicine Business Competition Winner (2019) Faculty Researcher of the Year (2019) Graduate Student of the Year (2013) He teaches pharmacology, pathophysiology, and entrepreneurship courses while mentoring healthcare innovators.

Gail ThomasView profile

Professor

• Cardiovascular Physiology
• Muscular Dystrophy
• Hypertension Research
• +3 more

Gail Thomas is a Professor in the Department of Medicine at the Penn State College of Medicine, affiliated with the Division of Cardiology, Penn State Clinical and Translational Science Institute (CTSI), and Penn State Heart and Vascular Institute. Her research focuses on cardiovascular physiology, with emphasis on skeletal muscle pathophysiology, hypertension, and mechanisms of vasoconstriction. Her work explores topics such as exercise pressor reflex modulation, nitric oxide signaling defects in muscular dystrophy, and translational research on cardiovascular treatments. Notable projects include studies on acid-sensing ion channels in exercise physiology and the role of oxidative stress in peripheral artery disease. Dr. Thomas has secured multiple grants from institutions like the National Institutes of Health (NIH), including projects investigating ischemia in muscular dystrophy and estrogen's role in vascular regulation. Her research has led to peer-reviewed publications in journals like Autonomic Neuroscience , American Journal of Physiology , and Hypertension .

• Neuroscience
• Neurodegenerative Diseases
• Cellular Neuroscience
• +3 more

Milan Stoiljkovic, MD, PhD is a Research Scientist in the Department of Comparative Medicine at Yale School of Medicine. His work focuses on neurophysiological mechanisms underlying brain disorders, particularly Alzheimer's disease and neurodegenerative conditions. He holds appointments across multiple disciplines including neuroscience, molecular biology, and translational medicine. Education & Training: MD: University of Niš School of Medicine (2002) PhD: University of Niš School of Medicine (2010) Postdoctoral Associate: Yale University School of Medicine (2015) Postdoctoral Associate: University of Illinois at Chicago (2006) Research Interests: Dr. Stoiljkovic's research integrates electrophysiological, genetic, and pharmacological approaches to study neuronal network dysfunctions. Key areas include: Alzheimer's disease biomarkers and therapeutic targets Cerebellar mechanisms in ataxia and motor disorders Role of microglia in neuroinflammation and behavioral disorders Neuronal oscillations in cognitive and affective processes His recent work highlights the critical role of LINE-1 retrotransposons in cerebellar ataxia and explores novel drug candidates targeting α7 nicotinic receptors. Publications Overview: Over 20 peer-reviewed articles since 2006. Recent work emphasizes translational neurophysiology, with contributions to understanding how network oscillations and molecular pathways contribute to disease pathogenesis. Key themes include hippocampal-cortical interactions, microglial-neuronal coupling, and cerebellar circuit dysfunction. Advising & Collaborations: Collaborates with multidisciplinary teams including Tamas Horvath, Leonard Kaczmarek, and Akiko Iwasaki. Active in mentoring postdoctoral researchers and graduate students through experimental neuroscience programs at Yale. Labs/Teams: Conducts research in Yale's Comparative Medicine laboratories, focusing on translational models of neurological disease using rodent and cellular systems.

• Neuroscience
• Synapse Biology
• Neurodevelopmental Disorders
• +5 more

Thomas Biederer is a Professor of Neurology and Associate Professor of Neuroscience at Yale University’s School of Medicine. He previously held faculty positions at Yale (2003–2019) and Tufts University (2013–2019). His research focuses on synapse biology, exploring mechanisms of synaptic formation, maturation, and dysfunction in neurological disorders like schizophrenia and Parkinson’s disease. He earned his Ph.D. in Cell Biology from Humboldt-Universität zu Berlin and completed postdoctoral training under Thomas Südhof at UT Southwestern. Key research areas include synaptogenic adhesion molecules (e.g., SynCAM proteins), synaptic cleft organization, and signaling pathways regulating dendritic development. His lab combines molecular biology, super-resolution imaging, and in vivo models to study how synaptic aberrations contribute to disease. Notable achievements include the 2025 Nature paper on human gene function modeling and discoveries about myo-inositol’s role in neuronal connectivity. Awards include the NARSAD Young Investigator Award (2009) and the Dana Foundation Scholar Award (2009). His work bridges basic science and translational research, with implications for neurodevelopmental and psychiatric disorders.

• Neuroscience
• Pain Management
• Sodium Channels
• +3 more

Peng Zhao is an Associate Research Scientist in Neurology at Yale School of Medicine, affiliated with the Center for Neuroscience and Regeneration Research. He holds a PhD from Shanghai Medical University (1999). His research focuses on sodium channel dysfunction in pain mechanisms, particularly exploring Nav1.7/Nav1.8 channels' roles in neuropathic pain, cannabinoid-based analgesia, and neuroinflammatory signaling. He collaborates extensively with leaders like Stephen Waxman and Sulayman Dib-Hajj. Key projects include elucidating phytocannabinoid targets for pain relief, TNF-α modulation of sodium channels, and high-throughput electrophysiological analysis of sensory neurons. His work bridges molecular neuroscience and translational pain research. Publications (2012–2025) emphasize sodium channel biophysics, toxin-channel interactions, and pain pathophysiology. Research has been featured in high-impact journals like Proceedings of the National Academy of Sciences and Nature Communications .

• Neuroscience
• Neurobiology
• Neuropeptide Signaling
• +3 more

Joel Greenwood is a Neuroscience Research Scientist and Director of the Neurotechnology Core at Yale School of Medicine. His research focuses on understanding neural circuits and neurological disorders using model organisms like zebrafish and mice. Key areas include neuropeptide signaling, epilepsy mechanisms, and neuronal excitability. He leads the Neurotechnology Core lab, advancing tools for neuroscience research. Publications span high-impact journals like Journal of Neuroscience and Annals of Neurology . Greenwood’s work bridges basic science and translational research, with contributions to neurodevelopmental and genetic epilepsy studies. Affiliations: Yale School of Medicine, Neuroscience Department Labs: Neurotechnology Core, Whisk Cup Streamline Group Research emphasizes In vivo behavioral analysis in zebrafish to dissect arousal pathways, alongside investigations into molecular mechanisms underlying seizures in genetic models. His lab develops neurotechnology tools to monitor and manipulate neural activity. Recent projects include studies on neuropeptide Y’s role in hippocampal function and collaborative work on tuberous sclerosis complex. Despite no explicitly listed awards, his work has been cited 293 times across four publications, reflecting significant academic impact.

• Neuroscience
• Immunology
• Gut Microbiome
• +3 more

Christopher Fields is an Associate Research Scientist at the Yale School of Medicine. He holds a PhD in Neuroscience from Georgia State University, an MS from Rockefeller University, and a BA in Biochemistry from Washington University. His research focuses on the intersection of gut microbiome, immunology, and behavioral neuroscience, particularly in understanding mechanisms linking gut dysbiosis to anxiety, compulsive behaviors, and movement disorders. He employs machine learning techniques to quantify behaviors in animal models and integrates sociological frameworks into addiction research. Recent work explores gut barrier dysfunction’s role in type 2 immunity and compulsive behavior, as well as sex-specific shifts in microbiota due to vasopressin deletion. He actively participates in academic discussions, including chairing the Social Neuroscience Discussion Series and presenting at conferences like the Society for Neuroscience. Key research interests include neuroimmunology, microbiome-brain interactions, and the application of computational methods to behavioral analysis. His publications span peer-reviewed journals in neuroscience, immunology, and virology, reflecting interdisciplinary approaches to understanding complex biological systems.

Arthur LaganowskyView profile

Professor

• Membrane Proteins
• Lipid-Protein Interactions
• Mass Spectrometry
• +4 more

Arthur Laganowsky is a Professor in the Department of Chemistry at Texas A&M University. His research focuses on elucidating molecular mechanisms of membrane protein-lipid interactions using native ion mobility mass spectrometry. His work bridges analytical chemistry and structural biology, with applications in drug discovery and understanding disease mechanisms. Educational Background : B.S., Biological Sciences, California State University, Chico (2004) M.S., Biological Sciences, California State University, Chico (2006) Ph.D., Chemistry and Molecular Biology, UCLA (2011) Postdoc, Physical and Theoretical Chemistry, University of Oxford (2011–2014) Research Interests : Dr. Laganowsky investigates how lipids modulate membrane protein structure and function, with a focus on potassium channels (Kir/K2P), ABC transporters, and RAS signaling complexes. His lab develops novel mass spectrometry techniques to probe lipid binding at the molecular level, including thermodynamic analysis and high-resolution structural studies. Key Awards : NIH New Innovator Award (2016) Lab & Opportunities : The Laganowsky Lab is located in the ILSB building at Texas A&M. They offer PhD and postdoctoral positions in membrane biophysics, mass spectrometry, and structural biology. Research opportunities include studying lipid-protein interactions in disease contexts such as cancer and neurological disorders.

Brigitte Le BoeufView profile

Associate Professor

• Biology
• Neuroscience
• Developmental Biology
• +5 more

Brigitte Le Boeuf is an Instructional Associate Professor in the Department of Biology at Texas A&M University, where she has been affiliated since 2017. Her academic background includes a B.S. in Biology from the University of Dallas and a Ph.D. in Biology from Texas A&M University. She specializes in teaching courses such as BIOL 402 (Communicating Biological Research to the Public) and BIOL 480 (Department Colloquium), both fulfilling Writing Intensive requirements for biology majors. Her research focuses on the neural and molecular mechanisms underlying male mating behavior in Caenorhabditis elegans , including programmed muscle remodeling, stress response pathways, and the interplay of ion channels and signaling molecules (e.g., Wnt, dopamine). She also explores reproductive physiology in aging worms and contributed to studies on artificial insemination protocols in lactating goats. Her work bridges developmental biology, cell physiology, and neurobiology, emphasizing how cellular processes coordinate complex behaviors. Notable trends in her publications include persistent exploration of how environmental stressors (e.g., starvation) and metabolic pathways influence reproductive behaviors. She frequently collaborates with researchers like Dr. L.R. Garcia, investigating dopaminergic systems and neuronal circuitry in model organisms. No scientific awards were explicitly mentioned in the provided text. In advising and grants, while no specific students or grant details are listed, her teaching and research roles suggest involvement in mentoring through course instruction and collaborative projects. Her research likely spans lab-based genetic, physiological, and behavioral studies, though explicit lab or team affiliations are not detailed in the text.

Evan IngleyView profile

Adjunct Associate Professor

• Cancer Biology
• Molecular Biology
• Cardiac Calcium Channels
• +5 more

Associate Professor Evan Ingley is a faculty member at The University of Western Australia (School of Biomedical Sciences, Department of Pharmacology and Toxicology), and holds an adjunct position. He leads the Cell Signalling Group at the Perkins Institute, focusing on disease signaling networks in cancer and cardiovascular systems. His work spans bone cancer metastasis, cardiac ion channels, and erythropoiesis. He has secured grants from NHMRC, Cancer Council WA, and RPH MRF. Education : PhD in Biochemistry and Molecular Biology (Australian National University, 1992) BSc(Hons) in Zoology (University of Canterbury, 1988) Research Interests : Current projects include: AFAP1L1 pathway in bone cancer metastasis Lyn/Src Family Kinase pathways in red blood cell longevity Personalized genomic medicine for sarcoma patients CRISPR/Cas9 editing of cardiac calcium channel variants Grants & Collaborations : Led projects on osteosarcoma therapies (NHMRC-funded) Collaborations with Prof. Livia Hool on cardiac ion channels Co-investigator on grants totaling $15M+ Labs & Teams : Leads the Cell Signalling Group, focusing on protein interactions, signaling networks, and translational cancer research.

Chris BladenView profile

Senior Lecturer

• Neuroscience
• Pain Management
• Epilepsy Research
• +3 more

Chris Bladen is an Honorary Senior Lecturer at Macquarie Medical School, Macquarie University. He holds a PhD in Neuroscience from the University of Calgary (2014) and certifications in Environmental Management. His work bridges Neuroscience and Environmental Science, focusing on ion channel physiology, cannabinoid-based therapies for epilepsy and chronic pain, and environmental remediation in oil sands mining. He has authored over 30 publications and led projects like the 2018 initiative on cannabinoid-derived pain therapies. Education: PhD in Neuroscience (University of Calgary, 2014); Environmental Management Certification (University of Calgary, 2017); B.Sc. in Freshwater Ecology (University of Wales, 1992) Research Interests: T-type calcium channel blockers, cannabinoid pharmacology, ion channel-drug interactions, environmental management of mining tailings. His work emphasizes translating ion channel research into clinical therapies, particularly leveraging cannabinoids for pain and epilepsy treatment. Publications span cannabinoid-channel interactions, analgesic development, and spider toxin analgesics. His 2023 studies highlight synthetic cannabinoids' effects on T-type channels and epilepsy. Collaborations include work on vasovagal responses and blood donor health. Grants/Projects: Led the 2018 project 'Developing next-generation pain therapies based on Cannabinoid derivatives' with Prof. Michael Connor. Active in interdisciplinary research at the Lifespan Health and Wellbeing Research Centre.

• Neuropharmacology
• Biochemistry
• Structural Biology
• +5 more

Professor Renae Ryan is a renowned academic at the University of Sydney, affiliated with the School of Biomedical Engineering and School of Medical Sciences. She holds an ARC Future Fellowship and leads research on membrane transport proteins, particularly glutamate transporters, linking their dysfunction to neurological diseases like episodic ataxia and cancer. Ryan earned her PhD from the University of Sydney in 2004, followed by postdoctoral work at Columbia University and NIH before returning to Sydney in 2007. She became a Professor in 2010. Education: PhD in Pharmacology (University of Sydney, 2004), postdoctoral research at Columbia University and NIH. Roles: Chair of SAGE Advisory Council, Academic Director of Science in Australia Gender Equity (SAGE) Program (2017–2022). Her research focuses on the molecular mechanisms of transport proteins, including their dual roles as transporters and chloride channels. Key areas include: Structural biology of glutamate transporters (e.g., 'twisting elevator' mechanism). Linking transporter mutations to diseases like episodic ataxia type 6. Developing therapeutics targeting amino acid transport in cancer. Recent articles highlight her work on glutamate transporter structure, chloride channel dysfunction in ataxia, and cancer cell nutrient uptake. Over 20 awards recognize her scientific contributions and leadership in gender equity. Grants: ARC Future Fellowship (2022), NHMRC Project Grants (e.g., targeting glutamate transport mechanisms). Advising: Supervised 11 PhD/MSc students, including Chelsea Briot and Natasha Freidman. International collaborations include work with McGill University (Don van Meyel), Weill Cornell (Olga Boudker), and NYU (Nicolas Abreu). Current projects explore cancer cell nutrient transport and therapeutic inhibitors for neurological disorders.